Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries

Authors: Severin Kabakama, Katherine E. Gallagher, Natasha Howard, Sandra Mounier-Jack, Helen E. D. Burchett, Ulla K. Griffiths, Marta Feletto, D. Scott LaMontagne, Deborah Watson-Jones

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

Social mobilisation during new vaccine introductions encourages acceptance, uptake and adherence to multi-dose schedules. Effective communication is considered especially important for human papillomavirus (HPV) vaccine, which targets girls of an often-novel age group. This study synthesised experiences and lessons learnt around social mobilisation, consent, and acceptability during 55 HPV vaccine demonstration projects and 8 national programmes in 37 low and middle-income countries (LMICs) between January 2007 and January 2015.

Methods

A qualitative study design included: (i) a systematic review, in which 1,301 abstracts from five databases were screened and 41 publications included; (ii) soliciting 124 unpublished documents from governments and partner institutions; and (iii) conducting 27 key informant interviews. Data were extracted and analysed thematically. Additionally, first-dose coverage rates were categorised as above 90 %, 90–70 %, and below 70 %, and cross-tabulated with mobilisation timing, message content, materials and methods of delivery, and consent procedures.

Results

All but one delivery experience achieved over 70 % first-dose coverage; 60 % achieved over 90 %. Key informants emphasized the benefits of starting social mobilisation early and actively addressing rumours as they emerged. Interactive communication with parents appeared to achieve higher first-dose coverage than non-interactive messaging. Written parental consent (i.e., opt-in), though frequently used, resulted in lower reported coverage than implied consent (i.e., opt-out). Protection against cervical cancer was the primary reason for vaccine acceptability, whereas fear of adverse effects, exposure to rumours, lack of project/programme awareness, and schoolgirl absenteeism were major reasons for non-vaccination.

Conclusions

Despite some challenges in obtaining parental consent and addressing rumours, experiences indicated effective social mobilisation and high HPV vaccine acceptability in LMICs. Social mobilisation, consent, and acceptability lessons were consistent across world regions and HPV vaccination projects/programmes. These can be used to guide HPV vaccination communication strategies without additional formative research.
Literature
1.
World Health Organization. Comprehensive cervical cancer prevention and control - a healthier future for girls and women. WHO guidance note. Geneva: World Health Organization; 2013. p. 12.
2.
3.
Markowitz LE, Dunne EF, Saraiya M. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2014;63(5):1–30.PubMed
4.
World Health Organization. Human Papillomavirus vaccines: WHO position paper October 2014. In: Weekly epidemiological record, vol. 89. 2014. p. 465–92.
5.
Cervical Cancer Action (CCA), Wittet S, Goltz S, Cody A. Progress in cervical cancer prevention: The CCA report card 2015. In: Cervical cancer action. 2015.
6.
LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, Janmohamed A, Kumakech E, Mosqueira NR, Nguyen NQ, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ. 2011;89(11):821–830B.CrossRefPubMedPubMedCentral
7.
World Health Organization. HPV vaccine communication: special considerations for a unique vaccine. Geneva: World Health Organization; 2013.
8.
9.
Paxman JM, Zuckerman RJ. Laws and policies affecting adolescent health. Geneva: World Health Organization; 1987.
10.
World Health Organization. Considerations regarding consent in vaccinating children and adolescents between 6 and 17 old. Geneva: World Health Organization; 2014. p. 8.
11.
Wani JA, Murokora D. Acceptability of HPV vaccine among young adolescent girls in Uganda: Young people’s perspectives count. Int J Child Adolesc Health. 2013;6(2):211.
12.
Ladner J, Besson MH, Rodrigues M, Audureau E, Saba J. Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health. 2014;14:670.CrossRefPubMedPubMedCentral
13.
Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization program. Vaccine. 2013;32:320–6.CrossRefPubMed
14.
Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine. 2006;24 Suppl 3:S3/201–209.
15.
Nan X, Zhao X, Briones R. Parental cancer beliefs and trust in health information from medical authorities as predictors of HPV vaccine acceptability. J Health Commun. 2014;19(1):100–14.CrossRefPubMed
16.
Jumaan AO, Ghanem S, Taher J, Braikat M, Al-Awaidy S, Dbaibo GS. Prospects and challenges in the introduction of human papillomavirus vaccines in the Extended Middle East and North Africa region. (Special Issue: Comprehensive control of HPV infections and related diseases in the extended Middle East and North Africa region.). Vaccine. 2013;31 Suppl 6:G58–64.CrossRefPubMed
17.
World Health Organization. Cervical cancer, human papillomavirus (HPV), and HPV vaccines : Key points for policy-makers and health professionals, vol. WHO/RHR/08.14. Geneva: World Health Organization, Department of Reproductive Health and Research; 2008. p. 16.
18.
19.
Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan’s suspension of its HPV vaccine recommendation. Hum Vaccin Immunotherapeutics. 2014;10(9):2543–50.CrossRef
20.
Gallagher KE, Griffiths UK, Burchett HED, Howard N, Kabakama S, Mounier-Jack S, Feletto M, LaMontagne DS, Watson-Jones D. Lessons learnt from human papillomavirus vaccine delivery in low and middle income countries. 2015. Abstract presented at 30th International Papillomavirus Conference, Lisbon, Portugal 17th-21st September 2015 (Abstract HPV15-0130).
21.
World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring. Geneva: World Health Organization; 2014.
22.
Watson-Jones D, Tomlin K, Remes P, Baisley K, Ponsiano R, Soteli S, Sanjosé S, Changalucha J, Kapiga S, Hayes RJ. Reasons for receiving or not receiving HPV vaccination in primary schoolgirls in Tanzania: a case control study. PLoS One. 2012;7:e45231.CrossRefPubMedPubMedCentral
23.
24.
Binagwaho A, Ngabo F, Wagner CM, Mugeni C, Gatera M, Nutt CT, Nsanzimana S. Integration of comprehensive women’s health programmes into health systems: Cervical cancer prevention, care and control in Rwanda. Bull World Health Organ. 2013;91(9):697–703.CrossRefPubMedPubMedCentral
25.
Tshomo U, Franceschi S, Dorji D, Baussano I, Tenet V, Snijders PJ, Meijer CJ, Bleeker MC, Gheit T, Tommasino M, et al. Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis. 2014;14:408.CrossRefPubMedPubMedCentral
26.
Galagan SR, Paul P, Menezes L, LaMontagne DS. Influences on parental acceptance of HPV vaccination in demonstration projects in Uganda and Vietnam. Vaccine. 2013;31(30):3072–8.CrossRefPubMed
27.
28.
PATH, Child Health and Development Centre (CHDC), The Uganda National Expanded Program on Immunization (UNEPI), The Uganda National Expanded Program on Immunization (UNEPI). HPV Vaccination in Africa: Lessons Learned From a Pilot Program in Uganda. Seattle: PATH; 2011.
29.
Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90(8):623–8.CrossRefPubMedPubMedCentral
30.
Botha MH, Van Der Merwe FH, Snyman L, Dreyer G. The vaccine and cervical cancer screen (VACCS) project-acceptance of human papilloma virus vaccination in a school based program. Int J Gynecol Cancer. 2014;4:821.
31.
Fregnani JHTG, Carvalho AL, Eluf Neto J, Ribeiro KCB, Kuil LM, Silva TA, Rodrigues SL, Mauad EC, Longatto Filho A, Villa LL. A school-based human papillomavirus vaccination program in Barretos, Brazil: final results of a demonstrative study. PLoS One. 2013;8(4):e62647.CrossRefPubMedPubMedCentral
32.
Vermandere H, Naanyu V, Mabeya H, Broeck DV, Michielsen K, Degomme O. Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya. PLoS One. 2014;9(10):e109353.CrossRefPubMedPubMedCentral
33.
Ayissi CA, Wamai RG, Oduwo GO, Perlman S, Welty E, Welty T, Manga S, Ogembo JG. Awareness, acceptability and uptake of human papilloma virus vaccine among Cameroonian school-attending female adolescents. J Community Health. 2012;37(6):1127–35.CrossRefPubMed
34.
Katz IT, Nkala B, Dietrich J, Wallace M, Bekker LG, Pollenz K, Bogart LM, Wright AA, Tsai AC, Bangsberg DR, et al. A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers. PLoS One. 2013;8(8):e72094.CrossRefPubMedPubMedCentral
35.
Katahoire AR, Wani JA, Murokora D, Mugisha E, LaMontagne DS. Acceptability of HPV vaccine among young adolescent girls in Uganda: Young people’s perspectives count. Int J Child Adolesc Health. 2013;6(2):211.
36.
Katagwa VN, Opio RO, Niwasasira DN, Onyege A, Naisanga M, Bongomin FA, Kitara DL. Acceptability of human papilloma virus vaccination among primary school girls in Minakulu sub-county, northern Uganda. Eur J Cancer Prev. 2014;23(4):294–5.CrossRefPubMedPubMedCentral
37.
Cover JK, Nghi NQ, LaMontagne DS, Huyen DTT, Hien NT, le Nga T. Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health. 2012;12(1):629.CrossRefPubMedPubMedCentral
38.
Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, Welty T, Manga S, Onyango MA, Ogembo JG. Awareness, knowledge and beliefs about HPV, cervical cancer and HPV vaccines among nurses in Cameroon: An exploratory study. Int J Nurs Stud. 2013;50(10):1399–406.CrossRefPubMed
39.
Kury CM, Kury MM, Silva RM, Oliveira FA, de Moraes JC, De Moraes JG, Pereira CC, Vieira BS. Implementation of the quadrivalent vaccine against HPV in the Municipality of Campos dos Goytacazes, Brazil–A combination of strategies to increase immunization coverage and early reduction of genital warts. Trials Vaccinology. 2013;2:19–24.CrossRef
40.
Paul P, LaMontagne DS, Le NT. Knowledge of cervical cancer and HPV vaccine post- vaccination among mothers and daughters in Vietnam. Asian Pac J Cancer Prev. 2012;13(6):2587–92.CrossRefPubMed
41.
Ogembo JG, Manga S, Nulah K, Foglabenchi LH, Perlman S, Wamai RG, Welty T, Welty E, Tih P. Achieving high uptake of human papillomavirus vaccine in Cameroon: Lessons learned in overcoming challenges. Vaccine. 2014;32(35):4399–403.CrossRefPubMed
42.
Watson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, Kapiga S, Mayaud P, de Sanjosé S, Wight D: HPV vaccination in Tanzanian schoolgirls: cluster-randomised trial comparing two vaccine delivery strategies. J Infect Dis 2012: doi: 10.​1093/​infdis/​jis407.
43.
Mugisha E, LaMontagne DS, Katahoire AR, Murokora D, Kumakech E, Seruyange R, Tsu VD. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda. Afr Health Sci. 2015;15(1):33–41.CrossRefPubMedPubMedCentral
44.
Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine. 2013;31(37):3811–7.CrossRefPubMedPubMedCentral
45.
Uganda Ministry of Health, PATH. Demonstration project for the introduction of human Papillomavirus vaccine in Uganda. training of health managers and service providers: facilitator’s guide. 2008.
46.
Dubé E, Gagnon D, Hamel D, Belley S, Gagné H, Boulianne N, Landry M, Bettinger JA. Parents’ and adolescents’ willingness to be vaccinated against serogroup B meningococcal disease during a mass vaccination in Saguenay–Lac-St-Jean (Quebec). Can J Infect Dis Med Microbiol. 2015;26(3):163–7.PubMedPubMedCentral
47.
Kelminson K, Saville A, Seewald L, Stokley S, Dickinson LM, Daley MF, Suh C, Kempe A. Parental views of school-located delivery of adolescent vaccines. J Adolesc Health. 2012;51(2):190–6.CrossRefPubMed
48.
Gargano LM, Herbert NL, Painter JE, Sales JM, Morfaw C, Rask K, Murray D, DiClemente R, Hughes JM. Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Hum Vaccin Immunotherapeutics. 2013;9(12):2627–33.CrossRef
49.
Bartolini RM, Drake JK, Creed-Kanashiro HM, Díaz-Otoya MM, Mosqueira-Lovón NR, Penny ME, Winkler JL, LaMontagne DS, Bingham A. Formative research to shape HPV vaccine introduction strategies in Peru. Salud Publica Mex. 2010;52(3):226–33.CrossRefPubMed
50.
Nghi NQ, LaMontagne DS, Bingham A, Rafiq M, le TP M, Lien NT, Khanh NC, Hong DT, Huyen DT, Tho NT, et al. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health. 2010;7(3):262–70.CrossRefPubMed
51.
Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, Siu G, Arinaitwe L, Bingham A, Mugisha E, Tsu V, et al. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health. 2008;12(3):159–72.PubMed
52.
Gottvall M, Tyden T, Larsson M, Stenhammar C, Hoglund AT. Informed consent for HPV vaccination: a relational approach. Health Care Anal. 2015;23(1):50–62.CrossRefPubMed
53.
54.
English A, Shaw FE, McCauley MM, Fishbein DB. Legal basis of consent for health care and vaccination for adolescents. Pediatrics. 2008;121(Supplement 1):S85–7.CrossRefPubMed
55.
56.
World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. 2nd ed. Geneva: World Health Organization; 2014.
57.
World Health Organization, PATH. Immunization in practice, a practical resource guide for health workers. Module 8: building community support for immunization. Geneva: World Health Organization; 2004.
58.
Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a randomized trial. Pediatrics. 2014;133(4):e835.CrossRefPubMed
59.
60.
Hendrix K, Finnell M, Zimet G, Sturm L, Lane K, Downs S. Vaccine message framing and parents’ intent to immunize their infants for MMR. Pediatrics. 2014;134(4):e675–83.CrossRefPubMedPubMedCentral
Metadata
Title
Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries
Authors
Severin Kabakama
Katherine E. Gallagher
Natasha Howard
Sandra Mounier-Jack
Helen E. D. Burchett
Ulla K. Griffiths
Marta Feletto
D. Scott LaMontagne
Deborah Watson-Jones
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-3517-8

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue

Research article

Lean fish consumption is associated with lower risk of metabolic syndrome: a Norwegian cross sectional study

Research article

Food safety knowledge of undergraduate students at a Canadian university: results of an online survey

Research article

User satisfaction with the structure and content of the NEXit intervention, a text messaging-based smoking cessation programme

Research article

Socioeconomic and race/ethnic disparities in observed park quality

Research article

Intra-individual variability in day-to-day and month-to-month measurements of physical activity and sedentary behaviour at work and in leisure-time among Danish adults

Research article

Prevalence and patterns of traditional bullying victimization and cyber-teasing among college population in Spain